Browse EX-10 agreements

PLEDGE AND SECURITY AGREEMENT

 

This PLEDGE AND SECURITY AGREEMENT (the “Agreement”) is made and entered into on June 30, 2026, by and between OS Therapies Incorporated, a corporation organized under the laws of the State of Delaware, OS Animal Health Inc., a corporation organized under the laws of the State of Delaware, and OS Therapies UK LTD, a limited company organized under the laws of the United Kingdom (collectively, the “Debtor”), and Leonite Fund I, LP, a limited partnership organized under the laws of the State of Delaware, and its permitted endorsees, transferees and assigns (collectively, the “Secured Party”).

 

RECITALS

…

SUPPLEMENT TO SUPPLY AND DISTRIBUTION AGREEMENT

This SUPPLEMENT (“Supplement”) to the SUPPLY AND DISTRIBUTION AGREEMENT, originally dated February 1, 2026 (the “Agreement”), by and between iPower Inc. (“Supplier”) and Global Product Marketing, Inc., a Nevada corporation (“Distributor”), and Supplier’s shareholder, ETTS AI Investment LLC, a Nevada limited liability Company (the “Shareholder”), is entered into this 30th day of June 2026 ("Effective Day"). Distributor and Supplier may each be referred to herein as a “Party” and collectively as the “Parties.”

 

RECITALS

WHEREAS, pursuant to the terms of the Agreement, the Parties agreed that Supplier would act as the exclusive supplier to the Distributor and, within that agreement sell certain designated inventory (the “SKUs”) held by the Supplier on to be agreed to terms; and

 

WHEREAS, Supplier now desires to sell $2,007,366.86 of to be determined SKUs to Distributor in exchange for Distributor assuming $2,007,366.86 in accounts payable owed to Supplier’s suppliers; and

…

Document

SIXTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT

    THIS SIXTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”), is made and entered into as of June 29, 2026 (the “Effective Date”), by and among HAVERTY FURNITURE COMPANIES, INC., a Maryland corporation (“HFC”), HAVERTYS CREDIT SERVICES, INC., a Tennessee corporation (“HCS” and, together with HFC, each, a “Borrower” and, collectively, the “Borrowers”), the financial institutions party hereto as lenders (the “Lenders”), and TRUIST BANK, in its capacities as administrative agent for the Lenders (together with its successors in such capacity, “Administrative Agent”) and as issuing bank (together with its successors in such capacity, “Issuing Bank”).

W I T N E S S E T H:

…

Document

Exhibit 10.1

EXECUTION VERSION

This FIRST AMENDMENT TO THE REVOLVING CREDIT AND SECURITY AGREEMENT (this “Amendment”), dated as of June 26, 2026 (the “First Amendment Date”), is entered into by and among ACI LIQUID AGGREGATOR SPV, LLC, a Delaware limited liability company, as borrower (the “Borrower”), BNP PARIBAS (“BNP”), as administrative agent for the Secured Parties (in such capacity, the “Administrative Agent”) and as Lender, ARES CORE INFRASTRUCTURE FUND, a Delaware statutory trust, as Equityholder (in such capacity, the “Equityholder”) and as servicer (in such capacity, the “Servicer”), and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as collateral agent for the Secured Parties (as hereinafter defined) (in such capacity, the “Collateral Agent”).

…

Document

CENTRAL PACIFIC FINANCIAL CORP. CENTRAL PACIFIC BANK CHANGE IN CONTROL AGREEMENT

THIS AGREEMENT is made     and entered into this _____ day of June, 2026 (the “Effective Date”), by and between Central Pacific Financial Corporation (“CPFC”) and Central Pacific Bank (the “Bank” and together with CPFC, the “Company”), and ____________________ (“Executive”), with reference to the following:

A.    Executive currently is employed by the Company as __________________. Executive is an experienced and knowledgeable individual whose creativity, expertise and effort have assisted in the development of the business and growth of the Company.

…

Document

CENTRAL PACIFIC FINANCIAL CORP. CENTRAL PACIFIC BANK CHANGE IN CONTROL AGREEMENT

THIS AGREEMENT is made     and entered into this _____ day of June, 2026 (the “Effective Date”), by and between Central Pacific Financial Corporation (“CPFC”) and Central Pacific Bank (the “Bank” and together with CPFC, the “Company”), and Arnold D. Martines (“Executive”), with reference to the following:

A.    Executive currently is employed by the Company as Chairman, President and Chief Executive Officer. Executive is an experienced and knowledgeable individual whose creativity, expertise and effort have assisted in the development of the business and growth of the Company.

…

Document

Exhibit 10.1

SECOND AMENDED AND RESTATED MANAGEMENT AGREEMENT

by and between

KKR Private Equity Conglomerate LLC

and

KKR DAV Manager LLC

---

AMENDED AND RESTATED MANAGEMENT AGREEMENT, dated as of July 2, 2026, by and between KKR Private Equity Conglomerate LLC, a Delaware limited liability company, and KKR DAV Manager LLC, a Delaware limited liability company (the “Manager”).

WHEREAS, the Company was formed as a limited liability company and intends to elect to be treated as a partnership for U.S. federal income tax purposes pursuant to the Internal Revenue Code of 1986, as amended (the “Code”);

WHEREAS, the Company and the Manager entered into a Management Agreement, dated as of July 27, 2023 (the “Original Agreement”);

WHEREAS, the Company and the Manager entered into an Amended and Restated Management Agreement, dated as of May 30, 2024, which amended and restated the Original Agreement in its entirety (the “A&R Agreement”);

WHEREAS, the Company and the Manager desire to amend and restate the A&R Agreement;

…

Document

Exhibit 10.2

AMENDED AND RESTATED DEALER-MANAGER AGREEMENT

THIS AMENDED AND RESTATED DEALER-MANAGER AGREEMENT (this “Agreement’) is made as of this 2nd day of July, 2026, by and between KKR Private Equity Conglomerate LLC, a Delaware limited liability company (the “Company”), and KKR Capital Markets LLC (the “Dealer-Manager”), a Delaware limited liability company.

WHEREAS, the Company is conducting a private placement offering in accordance with Rule 506(b) of Regulation D and Regulation S under the Securities Act of 1933, as amended (the “1933 Act”), of the classes of shares (the “Shares”) listed in the Company’s private placement memorandum in connection with such private placement offering (as amended and supplemented from time to time, the “Private Placement Memorandum”);

WHEREAS, the Company has filed a registration statement with the U.S. Securities and Exchange Commission (the “SEC”) pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “1934 Act”);

…

---

Exhibit 10.1

EXECUTION VERSION

 

CERTAIN INFORMATION IDENTIFIED BY “[***]” HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

 

INVESTMENT AGREEMENT

 

dated as of July 1, 2026

 

by and among

 

BridgeBio Pharma, Inc.

 

and

 

the Purchasers identified herein

 

---

TABLE OF CONTENTS

 

 

Page

 

 

 

ARTICLE I

 

PURCHASE; CLOSING

 

 

 

Section 1.1

Purchase

1

Section 1.2

Closing

1

 

 

 

ARTICLE II

 

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

 

 

Section 2.1

Organization and Authority

2

Section 2.2

Capitalization

2

Section 2.3

Authorization

3

Section 2.4

Sale and Status of Securities

4

Section 2.5

SEC Documents; Financial Statements

5

Section 2.6

Undisclosed Liabilities

5

Section 2.7

Absence of Changes

5

Section 2.8

Brokers and Finders

6

Section 2.9

Registration Rights

6

Section 2.10

Compliance with Laws; Anti-Corruption; Trade Controls

6

Section 2.11

Listing and Maintenance Requirements

7

…

---

Exhibit 10.2

EXECUTION VERSION

 

 REGISTRATION RIGHTS AGREEMENT

 

of

 

BridgeBio Pharma, Inc.

 

dated as of July 1, 2026

 

---

TABLE OF CONTENTS

 

 

 

 

Page

 

 

 

 

Definitions

1

Registration Rights

4

 

(a)

Shelf Registration

4

 

(b)

Automatic Shelf Registration Statements

4

 

(c)

Continued Effectiveness

4

 

(d)

Postponements in Requested Registrations

4

 

(e)

Registration Expenses

4

Registration Procedures

5

Indemnification

8

 

(a)

Indemnification by the Company

8

 

(b)

Indemnification by the Stockholders of Registrable Securities

8

 

(c)

Conduct of Indemnification Proceedings

9

 

(d)

Contribution

9

 

(e)

Non-Exclusivity

10

Registration Expenses

10

Rule 144

10

Miscellaneous

10

 

(a)

Termination

10

 

(b)

Amendments and Waivers

11

 

(c)

Successors, Assigns and Transferees

11

 

(d)

Notices

11

 

(e)

Further Assurances

12

 

(f)

No Inconsistent Agreements

12

 

(g)

Entire Agreement; No Third Party Beneficiaries

12

 

(h)

…

SECURITIES PURCHASE AGREEMENT

BY AND AMONG

PYXIS ONCOLOGY, INC.,

AND

THE PURCHASERS

AS SET FORTH HEREIN

June 30, 2026

 

 

 

 

 

 

 

 

 

 

 

 

---

TABLE OF CONTENTS

Definitions

1

Purchase and Sale of Securities

6

2.1

Purchase and Sale

6

2.2

Closing

6

Representations and Warranties of the Company

7

3.1

Organization and Power

7

3.2

Capitalization

7

3.3

Registration Rights

7

3.4

Authorization

7

3.5

Valid Issuance

8

3.6

No Conflict

8

3.7

Consents

9

3.8

SEC Filings; Financial Statements

9

3.9

Absence of Changes

10

3.10

Absence of Litigation

10

3.11

Compliance with Law; Permits

10

3.12

Intellectual Property

11

3.13

Employee Benefits

11

3.14

Taxes

12

3.15

Environmental Laws

12

3.16

Title

12

3.17

Insurance

13

3.18

Nasdaq Stock Market

13

3.19

Sarbanes-Oxley Act

13

3.20

Clinical Data and Regulatory Compliance

13

3.21

Compliance with Health Care Laws

14

3.22

Accounting Controls and Disclosure Controls and Procedures

15

3.23

Price Stabilization of Common Stock

15

3.24

…

Exhibit 10.2

 

 

REGISTRATION RIGHTS AGREEMENT

 

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 2, 2026, is entered into by and among PYXIS ONCOLOGY, INC., a Delaware corporation (the “Company”), and the several investors signatory hereto (individually as an “Investor” and collectively together with their respective permitted assigns, the “Investors”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and among the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

 

WHEREAS:

 

A.

…